Suzetrigine for pain relief after thumb joint replacement surgery
Tests suzetrigine for pain after thumb joint surgery in people with thumb osteoarthritis.
Key facts
- Who runs it
- Rothman Institute Orthopaedics
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Registry title
- Journavx to Treat Pain After Thumb Basal Joint Arthroplasty
- Status
- Enrolling by invitation
- People taking part
- 100 people, planned
- Started
- 21 Jul 2026
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Treatments tested
- suzetrigine 100mg
- Acetaminophen
- Record updated
- 23 July 2026
Who can take part
The trial is looking for adults having thumb basal joint replacement surgery (arthroplasty). It tests suzetrigine with acetaminophen for pain after surgery.
- Age
- 40 to 80 years
- Sex
- All sexes
- Disease stage
- People having thumb basal joint arthroplasty (BJA).
- Earlier treatment
- People who had surgery on the study hand within the last 6 months cannot join. People now using a prescription pain medicine other than the study medicines cannot join.
- Main reasons for not taking part
- Past substance abuse or long-term opioid use
- Allergy to acetaminophen, oxycodone or suzetrigine
- Severe kidney or liver problems, eGFR less than 15 ml/min/1.73m^2, Child-Pugh Class C, liver failure, active hepatitis or past kidney transplant
- Pregnant, planning pregnancy or breastfeeding
- Use of strong or moderate CYP3A inhibitors or inducers, or medicines known to interact with suzetrigine
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Aged 40-80 years
- Undergoing thumb basal joint arthroplasty (BJA)
- Able to provide informed consent
- Willing to comply with the study procedures
Who cannot take part
- Has had prior surgery on the study hand within the last 6 months
- Use of strong or moderate CYP3A inhibitors or inducers, or medications known to interact with suzetrigine
- Currently using a prescription pain medication other study medications
- History of substance abuse or chronic opioid use
- Known allergies to acetaminophen, oxycodone, or suzetrigine
- History of kidney transplant
- History of liver failure
- Active hepatitis that can adversely influence hepatic function
- Severe renal or hepatic dysfunction
- Estimated glomerular filtration rate less than 15 ml/min/1.73m\^2
- Child-Pugh Class C
- Is currently pregnant, planning to be pregnant, or breastfeeding
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Thumb basal joint osteoarthritis or postoperative pain or joint replacement
Where in United States
- Rothman Orthopaedic InstitutePhiladelphia, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of this study is to find out how well suzetrigine, a newly FDA-approved non-opioid pain medication, works to relieve pain after thumb basal joint replacement surgery. The researchers believe that suzetrigine may provide effective pain relief during recovery without the use of opioid medications.
The group in the trial
- Participants undergoing thumb Basal Joint Replacement Surgery
Participants undergoing thumb Basal Joint Replacement Surgery receive suzetrigine (100 mg loading dose followed by 50 mg every 12 hours for 5 days) in combination with acetaminophen (Tylenol).
Treatment: suzetrigine 100mg and Acetaminophen
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Single-Arm Open-Label Trial Evaluating the Efficacy of Suzetrigine (Journavx) in Multimodal Postoperative Pain Management Following Thumb Basal Joint Arthroplasty
- Plain-language title
- Suzetrigine for pain relief after thumb joint replacement surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07723352, who can take part
- Record updated
- 23 July 2026